Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
1996-07-30^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68b9bc89a8739f17852808c122908325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3828f6e1fb3b3d11aa95b9eeaa8dc98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e7e45de4deb604a7a11ca4caf2a1d9 |
publicationDate |
1998-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5814642-A |
titleOfInvention |
Tetracyclic condensed heterocyclic compounds their production, and use |
abstract |
A novel compound of the formula <IMAGE> wherein Ar represents a tetracyclic fused heterocyclic group which may be substituted; R1 represents H or a hydrocarbon group which may be substituted; Y represents an amino acid or nitrogen-containing saturated heterocyclic group which may be substituted, its salt, inhibiting excellent cholinesterase inhibitory activity and monoamine uptake inhibitory activity, thus being useful as therapeutic and/or prophylactic medicaments of senile dementia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005143350-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977331-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007049593-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7659263-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009036444-A1 |
priorityDate |
1993-11-30^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |